APA (7th ed.) Citation

Mostafa, A., Kandeil, A., A. M. M. Elshaier, Y., Kutkat, O., Moatasim, Y., Rashad, A. A., . . . Ali, M. A. (2020). FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals (Basel, Switzerland), 13(12), 443. https://doi.org/10.3390/ph13120443

Chicago Style (17th ed.) Citation

Mostafa, Ahmed, et al. "FDA-Approved Drugs with Potent In Vitro Antiviral Activity Against Severe Acute Respiratory Syndrome Coronavirus 2." Pharmaceuticals (Basel, Switzerland) 13, no. 12 (2020): 443. https://doi.org/10.3390/ph13120443.

MLA (9th ed.) Citation

Mostafa, Ahmed, et al. "FDA-Approved Drugs with Potent In Vitro Antiviral Activity Against Severe Acute Respiratory Syndrome Coronavirus 2." Pharmaceuticals (Basel, Switzerland), vol. 13, no. 12, 2020, p. 443, https://doi.org/10.3390/ph13120443.